Aaron's Co Inc (The) Com 주식 (NYSE: AAN)

에 대한 최신 뉴스 Aaron's Co Inc (The) Com (NYSE:AAN) 주식

Aarons

Technicals

Small Cap

Trading Ideas

월스트리트에는 &#39;갭 리필(Gap refill)&#39;이라는 옛말이 있다. 이는 사실이며 아론스 홀딩스 컴퍼니(NYSE:AAN)의 차트에서 확인할 수 있다. 이 기사에서는 이것이 사실인 이유와 발생하는 이유를 설명한다. 금융 시장에서 중요한 역학은 이전에 지지선에서 저항선으로 전환되었던 가격 수준이다. 이는 매수자의 변심으로 인해 발생한다.

오늘의 주식: 아론스 홀딩스 회사의 차트가 가르쳐주는 중요한 교훈

ALCOA ORD

Aaron's Co Inc (The) Com

Aroundtown SA

<a href="https://www.jcapitalresearch.com/index.htmlv">https://www.jcapitalresearch.com/index.htmlv</a>
&nbsp;
<a href="https://www.jcapitalresearch.com/uploads/2/0/0/3/20032477/2024_09_03_aan.pdf" title="https://www.jcapitalresearch.com/uploads/2/0/0/3/20032477/2024_09_03_aan.pdf">https://www.jcapitalresearch.com/uploads/2/0/0/3/20032477/2024_09_03_aan.pdf</a>

News

Short Sellers

Watchings Aarons; J Capital Research Issues Report On Co Titled "​Will the feds halt AAN's go-private deal? The Aaron's Company looks like it's hiding the real buyer"

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments">high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer discretionary sector.
<h3 class="wp-block-heading">Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>)</h3>
<ul>
<li>Dividend Yield: 6.13%</li>
<li>Goldman Sachs analyst Mark Delaney maintained a Neutral rating and cut the price target from $14 to $12 on July 25. This analyst has an accuracy rate of 76%.</li>
<li>Piper Sandler analyst Alexander Potter initiated coverage on the stock with a Neutral rating and a price target of $13 on March 15. This analyst has an accuracy rate of 77%.</li>
<li>Recent News: On Aug. 2, Ford Motor said it sold 31% more EVs in the U.S. last month than last year, thanks to the rising popularity of its EV pickup truck.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080724&amp;t=be2bearmibe3na1">alerted to latest Ford news.</a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="916" height="831" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051253/image-1-13.png" alt="" class="wp-image-481013" style="width:485px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051253/image-1-13.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051253/image-1-13-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051253/image-1-13-768x697.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure>
<h3 class="wp-block-heading">Carter&#8217;s, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>)</h3>
<ul>
<li>Dividend Yield: 5.21%</li>
<li>Wells Fargo analyst Ike Boruchow maintained an Equal-Weight rating and lowered the price target from $75 to $68 on April 24. This analyst has an accuracy rate of 72%.</li>
<li>UBS analyst Jay Sole maintained a Neutral rating and raised the price target from $76 to $79 on Feb. 28. This analyst has an accuracy rate of 72%.</li>
<li>Recent News: On July 26, Carter&#8217;s issued weak guidance.</li>
<li>Benzinga Pro&#8217;s charting tool helped i<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080724&amp;t=be2bearmibe3na1">dentify the trend in CRI's stock</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="911" height="831" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051347/image-29.png" alt="" class="wp-image-481017" style="width:506px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051347/image-29.png 911w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051347/image-29-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051347/image-29-768x701.png 768w" sizes="(max-width: 911px) 100vw, 911px" /></a></figure>
<h3 class="wp-block-heading">The Aaron&#8217;s Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>)</h3>
<ul>
<li>Dividend Yield: 4.98%</li>
<li>Truist Securities analyst Scot Ciccarelli maintained a Hold rating and raised the price target from $8 to $10.1 on June 18. This analyst has an accuracy rate of 72%.</li>
<li>TD Cowen analyst Hoang Nguyen maintained a Hold rating and raised the price target of $8 to $10.1 on June 17. This analyst has an accuracy rate of 71%.</li>
<li>Recent News: On Aug. 5, Aaron&#8217;s posted weaker-than-expected quarterly results.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080724&amp;t=be2bearmibe3na1">breakout in AAN shares</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="881" height="835" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051432/image-30.png" alt="" class="wp-image-481019" style="width:509px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051432/image-30.png 881w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051432/image-30-300x284.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051432/image-30-768x728.png 768w" sizes="(max-width: 881px) 100vw, 881px" /></a></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40194186/top-4-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 4 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Wall Street's Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields

Aarons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $0.04 by 275 percent. The company reported quarterly sales of $503.125 million which missed the analyst consensus estimate of $515.674 million by 2.43 percent. This is a 5.14 percent decrease over sales of $530.372 million the same period last year.

Earnings

Earnings Misses

Aarons Q2 2024 Adj. EPS $(0.07) Misses $0.04 Estimate, Sales $503.125M Miss $515.674M Estimate

Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Fortress Biotech</h3>
<ul>
<li>The Trade: Fortress Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBIO#NASDAQ">FBIO</a>) President, CEO and Chairman Lindsay A MD Rosenwald <a href="https://www.benzinga.com/quote/FBIO/analyst-ratings">acquired a total of 5,000 shares</a> at an average price of $7.35. To acquire these shares, it cost around $36,765.</li>
<li>What's Happening: On July 5, Fortress Biotech reported a pause in the payment of dividends on its 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock.</li>
<li>What Fortress Biotech Does: Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products.</li>
</ul>
<h3 class="wp-block-heading">Aaron&#8217;s Company</h3>
<ul>
<li>The Trade: The Aaron&#8217;s Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) EVP, Gen Counsel/Corp Sec Rachel G George acquired a total of 500 shares at an average price of $8.48. To acquire these shares, it cost around $4,240.</li>
<li>What's Happening: On July 10, Jefferies analyst Kyle Joseph downgraded Aarons from Buy to Hold and lowered the price target from $11 to $10.1.</li>
<li>What Aaron&#8217;s Does: The Aarons Co Inc is a specialty retailer that has developed a lease-to-own model.</li>
</ul>
<h3 class="wp-block-heading">NexPoint Diversified Real Estate Trust</h3>
<ul>
<li>The Trade: NexPoint Diversified Real Estate Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXDT#NYSE">NXDT</a>) Matt McGraner <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 15,000 shares</a> at an average price of $5.37. To acquire these shares, it cost around $80,600.</li>
<li>What's Happening: On June 20, NexPoint Real Estate Opportunities, LLC announced its nomination of four highly qualified, independent candidates for election to the UDF IV Board of Trustees at its upcoming Annual Meeting of Shareholders.</li>
<li>What NexPoint Diversified Real Estate Trust Does: NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39708358/wall-streets-most-accurate-analysts-weigh-in-on-3-consumer-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>

Long Ideas

Insider Trades

FBIO

NXDT

Insiders Buying Fortress Biotech And 2 Other Stocks

During the last three months, 5 analysts shared their evaluations of Aarons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>), revealing diverse outlooks from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $9.66, along with a high estimate of $10.10 and a low estimate of $8.00. This current average has increased by 9.77% from the previous average price target of $8.80. 
<img src="https://www.benzinga.com/files/images/story/2024/1720612892_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Aarons among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kyle Joseph</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$10.10</td>
<td>$11.00</td>
</tr>
<tr>
<td>Anthony Chukumba</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Hold</td>
<td>$10.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$10.10</td>
<td>$8.00</td>
</tr>
<tr>
<td>Hoang Nguyen</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$10.10</td>
<td>$8.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$8.00</td>
<td>$9.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Aarons. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Aarons compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Aarons's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AAN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Aarons analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Aarons's Background</h2>
The Aarons Co Inc is a specialty retailer that has developed a lease-to-own model. It serves customers through the sale and lease ownership of furniture, consumer electronics, computers, home appliances, and other accessories with the highest quality products. Aaron's services are available through multiple channels to approximately 40-50 % of the U.S. population. The Company conducts its operations through two primary operating business segments: Aaron's Business and BrandsMart.
<h3>Aarons: A Financial Overview</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Aarons's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -7.73%. This indicates a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -2.77%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Aarons's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -2.09%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Aarons's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.79%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 1.05, Aarons faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Ratings For Aarons

Jefferies analyst Kyle Joseph downgrades Aarons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) from Buy to Hold and lowers the price target from $11 to $10.1.

Downgrades

Jefferies Downgrades Aarons to Hold, Lowers Price Target to $10.1

Ratings for Aarons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $9.55, a high estimate of $10.10, and a low estimate of $8.00. Surpassing the previous average price target of $8.25, the current average has increased by 15.76%.
<img src="https://www.benzinga.com/files/images/story/2024/1718722839_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Aarons. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anthony Chukumba</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Hold</td>
<td>$10.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$10.10</td>
<td>$8.00</td>
</tr>
<tr>
<td>Hoang Nguyen</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$10.10</td>
<td>$8.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$8.00</td>
<td>$9.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Aarons. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Aarons compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Aarons's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Capture valuable insights into Aarons's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AAN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Aarons analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Aarons</h2>
The Aarons Co Inc is a specialty retailer that has developed a lease-to-own model. It serves customers through the sale and lease ownership of furniture, consumer electronics, computers, home appliances, and other accessories with the highest quality products. Aaron's services are available through multiple channels to approximately 40-50 % of the U.S. population. The Company conducts its operations through two primary operating business segments: Aaron's Business and BrandsMart.
<h3>Aarons's Financial Performance</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Aarons's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2024, the company experienced a revenue decline of approximately -7.73%. This indicates a decrease in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Aarons's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -2.77%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Aarons's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -2.09%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.79%, the company showcases effective utilization of assets.
Debt Management: Aarons's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.05, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 4 Analysts Discuss Aarons Stock

Loop Capital analyst Anthony Chukumba maintains Aarons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) with a Hold and raises the price target from $8 to $10.

Loop Capital Maintains Hold on Aarons, Raises Price Target to $10

Truist Securities analyst Scot Ciccarelli maintains Aarons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) with a Hold and raises the price target from $8 to $10.1.

Truist Securities Maintains Hold on Aarons, Raises Price Target to $10.1

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, but the index remained in the &#8220;Fear&#8221; zone on Monday.
U.S. stocks recorded gains on Monday, with the S&amp;P 500 settling at a fresh record high level during the session. The S&amp;P 500 and Nasdaq notched their seventh weekly surge in eight weeks.
On the economic data front, the NY Empire State Manufacturing Index rose to -6 in June versus a reading of -15.6 in May and coming in better than market expectations of -12.50.
Shares of The Aaron's Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) jumped around 33% on Monday after the company announced that it entered into a definitive agreement to be acquired by IQVentures Holdings.
Most sectors on the S&amp;P 500 closed on a positive note, with industrials, information technology and consumer discretionary stocks recording the biggest gains on Monday. However, utilities and real estate stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 189 points to 38,778.10 on Monday. The S&amp;P 500 gained 0.77% at 5,473.23, while the Nasdaq Composite climbed 0.95% at 17,857.02 during Friday's session.
Investors are awaiting earnings results from Patterson Companies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDCO#NASDAQ">PDCO</a>), KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) and America&#8217;s Car-Mart, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 42, the index remained in the &#8220;Fear&#8221; zone on Monday, versus a prior reading of 38.6.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/06/39357158/23m-bet-on-pbf-energy-check-out-these-4-stocks-insiders-are-buying">$23M Bet On PBF Energy? Check Out These 4 Stocks Insiders Are Buying</a>

CRMT

PDCO

S&P 500, Nasdaq Close At Record Highs As Wall Street Turns Bullish Amid Improving Investor Sentiment

There&rsquo;s an old saying on Wall Street -&nbsp;&quot;Gaps refill.&quot; It&rsquo;s true, and it can be seen on the chart of Aaron&rsquo;s Holdings Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aan#NYSE">AAN</a>). 
In this article, we will explain why it&rsquo;s true <a href="https://www.benzinga.com/trading-ideas/technicals">and why it happens.</a>
An important dynamic in the financial markets is price levels that had previously been support converting into resistance. This occurs due to buyer&rsquo;s remorse.
People buy, and then regret doing so if the price falls below the price they paid. Some decide to get out if the price rises back to their entry level, and they can sell at breakeven. 
As a result, if the stock rallies back up to their buy price, they place sell orders at that level. If there are enough sell orders, it will cause resistance to form at the price that had been support.
This can be seen on the chart. The $11.80 level acted as support in August 2023. Then it was resistance in December 2023.
Another important market dynamic is price levels that had been resistance turning into support. This can also be seen on the chart as $10.80 was resistance in September 2023, then it became support the following January.
This happens because of sellers&#39;&nbsp;remorse. Some investors and traders regret selling if the price moves higher. A number of them vow to buy their shares back, but only if they can get them for the same price at which they were sold.
So, they place buy orders at a price that had been resistance. If there are enough of these buy orders it will turn the price that was resistance into support.
Also Read:<a href="https://www.benzinga.com/top-stories/24/06/39365183/warning-flags-expert-says-nvidia-in-bubble-ish-territory-points-to-potential-market-pullback">&nbsp;&#39;Warning Flags&#39;: Expert Says Nvidia In &#39;Bubble-ish Territory,&#39; Points To Potential Market Pullback</a> 
<img alt="" src="https://www.benzinga.com/files/u449135/aaron_chart.png" style="height:319px; width:623px" />
A &quot;gap&quot;&nbsp;occurs when a stock closes at one price, and then opens the next day at a different one. There is no trading at the levels between these two prices. As a result, there are no traders or investors who bought or sold within this range. This means there won&rsquo;t be remorseful buyers or sellers trying to sell or buy their shares back.
So, if a stock gaps through price levels going one way and then eventually reverses and gets back to those same levels going in the opposite direction, there&rsquo;s a tendency to move back through them rapidly because of the lack of buy or sell interest.
This would cause the gap to &quot;refill.&quot;
In April 2023 AAN gapped from $10.22 to $12.25. As you can see on the chart, this gap was filled the following August.
In October 2023, shares gapped down from $8.89 to $7.28. The stock reversed and refilled this gap in November.
There are a lot of sayings on Wall Street, &quot;gaps refill&quot;&nbsp;is one of them and it&rsquo;s true
Now Read:&nbsp;<a href="https://www.benzinga.com/general/gaming/24/06/39362295/gamestop-shareholders-meeting-highlights-actions-speak-louder-than-words-says-ceo-ryan-cohen">GameStop Shareholders Meeting Highlights: &#39;Actions Speak Louder Than Words,&#39; Says CEO Ryan Cohen</a>
Image created using artificial intelligence via Midjourney.

Stock Of The Day: Chart Of Aaron's Holding Company Teaches Important Lessons

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging over 200 points on Monday.
The Dow traded up 0.57% to 38,807.47 while the NASDAQ rose 1.22% to 17,904.35. The S&amp;P 500 also rose, gaining, 0.95% to 5,483.45.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/06/39354484/top-4-risk-off-stocks-that-may-rocket-higher-in-q2">Top 4 Risk Off Stocks That May Rocket Higher In Q2</a>
Leading and Lagging Sectors Consumer staples shares jumped by 1.5% on Monday.
In trading on Monday, real estate shares fell by 0.6%.
Top Headline
The NY Empire State Manufacturing Index rose to -6 in June versus a reading of -15.6 in May and coming in better than market expectations of -12.50.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Mustang Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares shot up 352% to $0.5852 after the company announced safety and efficacy data from the complete Waldenstrom Macroglobulinemia cohort of its Phase 1/2 clinical trial of MB-106, showing an overall response rate of 90% with one patient remaining in complete remission at 31 months.</li>
<li>Shares of Allego N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLG#NASDAQ">ALLG</a>) got a boost, surging 128% to $1.6750 after the company and its majority shareholder, Meridiam, announced a transaction framework agreement under which Meridiam will launch a tender offer for all issued and outstanding Allego shares not owned by Meridiam, with the option to tender shares for $1.70 per share in cash.</li>
<li>The Aaron&#8217;s Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) shares were also up, gaining 33% to $10.01 after the company announced that it entered into a definitive agreement to be acquired by IQVentures Holdings.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Aerovate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTE#NASDAQ">AVTE</a>) shares dropped 93% to $2.1450. Aerovate Therapeutics released topline results from the Phase 2b portion of the IMPAHCT Phase 2b/3 trial of AV-101, a dry powder inhaled formulation of imatinib, for pulmonary arterial hypertension (PAH).</li>
<li>Shares of Workhorse Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) were down 29% to $2.1450 as the stock begins trading on a split-adjusted basis. Workhorse announced a 1-for-20 reverse stock split of its common stock last week after shareholders approved the move at the company's annual meeting of stockholders in May.</li>
<li>Ovid Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OVID#NASDAQ">OVID</a>) was down, falling 70% to $0.9756 after Takeda&#8217;s Skyline study in Dravet syndrome missed its primary endpoint</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/earnings/24/06/39355343/how-to-earn-500-a-month-from-steelcase-stock-ahead-of-q1-earnings-report">How To Earn $500 A Month From Steelcase Stock Ahead Of Q1 Earnings Report</a>
Commodities In commodity news, oil traded up 1.8% to $79.89 while gold traded down 0.9% at $2,328.90.
Silver traded down 0.3% to $29.38 on Monday, while copper fell 1.2% to $4.4435.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 gained 0.09%, Germany's DAX rose 0.37% and France's CAC 40 gained 0.91%. Spain's IBEX 35 Index fell 0.30%, while London's FTSE 100 slipped 0.06%.
Wages in the Eurozone increased 5.3% year-over-year in the first quarter, while hourly labor costs climbed by 5.1% annually in the quarter.
Spain&#8217;s trade gap widened to EUR 4.7 billion in April from EUR 4.4 billion in the year-ago month. Italy's annual inflation rate came in unchanged at 0.8% in May.
Asia Pacific Markets
Asian markets closed lower on Monday, with Japan's Nikkei falling 1.83%, Hong Kong's Hang Seng Index declining 0.03% and China's Shanghai Composite Index dipping 0.55%.
China&#8217;s retail sales climbed by 3.7% year-over-year in May, while industrial production rose by 5.6% year-over-year in May. China's new home prices fell by 3.9% year-over-year during the month of May. The People's Bank of China kept the interest rate unchanged at 2.50% during its recent meeting. Japanese core machinery orders slipped l 2.9% month-over-month to 885.3 billion yen in April.
Economics
The NY Empire State Manufacturing Index rose to -6 in June versus a reading of -15.6 in May and coming in better than market expectations of -12.50.
Now Read This: <a href="https://www.benzinga.com/news/24/06/39354679/this-analyst-with-86-accuracy-rate-sees-over-13-upside-in-alphabet-here-are-5-stock-picks-for-last-w">This Analyst With 86% Accuracy Rate Sees Over 13% Upside In Alphabet &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a>

Eurozone

Commodities

Intraday Update

ALLG

AVTE

MBIO

OVID

WKHS

Nasdaq Surges Over 200 Points; Aaron's Shares Jump

Shares of Ovid Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OVID#NASDAQ">OVID</a>) dipped 65.7% to $1.1285 after Takeda&#8217;s Skyline study in Dravet syndrome missed its primary endpoint.
Takeda Pharmaceutical Co Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAK#NYSE">TAK</a>) announced topline data from its SKYLINE and SKYWAY Phase 3 studies of Soticlestat (TAK-935) for the treatment of Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS).
AMMO shares dipped 19.1% to $2.0306 on Friday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Interactive Strength Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) shares climbed 148% to $7.07 after dipping 19% on Friday.</li>
<li>Mustang Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares jumped 145% to $0.32 after the company announced safety and efficacy data from the complete Waldenstrom Macroglobulinemia cohort of its Phase 1/2 clinical trial of MB-106, showing an overall response rate of 90% with one patient remaining in complete remission at 31 months.</li>
<li>Allego N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLG#NASDAQ">ALLG</a>) gained 126.4% to $1.6750 after the company and its majority shareholder, Meridiam, announced a transaction framework agreement under which Meridiam will launch a tender offer for all issued and outstanding Allego shares not owned by Meridiam, with the option to tender shares for $1.70 per share in cash.</li>
<li>Scinai Immunotherapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) shares gained 92.6% to $6.74 after surging 24% on Friday. Scinai Immunotherapeutics, last week, received a non-binding Letter of Intent from the European Investment Bank for converting loan into equity.</li>
<li>TRxADE HEALTH, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDS#NASDAQ">MEDS</a>) rose 47% to $9.50.</li>
<li>The Aaron&#8217;s Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) gained 32.2% to $9.97 after the company announced that it entered into a definitive agreement to be acquired by IQVentures Holdings.</li>
<li>AgriFORCE Growing Systems Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGRI#NASDAQ">AGRI</a>) jumped 27% to $0.1044 after the company announced a $1 million share repurchase program.</li>
<li>Xponential Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) surged 21.3% to $13.68. Xponential Fitness announced the appointment of Mark King as Chief Executive Officer.</li>
<li>Silynxcom Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYNX#NASDAQ">SYNX</a>) gained 21.8% to $3.14.</li>
<li>Venus Concept Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) gained 13.6% to $1.0650 after the company announced that it has entered a new strategic resurfacing and skin tightening device supply arrangement with Skin Laundry Holdings.</li>
<li>Envirotech Vehicles, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVTV#NASDAQ">EVTV</a>) rose 12.8% to $1.4899.</li>
<li>CNS Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) gained 12.8% to $3.1459. CNS Pharmaceuticals recently announced pricing of registered direct offering and concurrent private placement.</li>
<li>ENDRA Life Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDRA#NASDAQ">NDRA</a>) gained 11.8% to $0.1159 after a 13G filing showed a 9.99% passive stake from S.H.N. Financial Investments Ltd.</li>
<li>Lexicon Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXRX#NASDAQ">LXRX</a>) climbed 10.5% to $2.0099. HC Wainwright &amp; Co. analyst Joseph Pantginis initiated coverage on Lexicon Pharmaceuticals with a Buy rating and announced a price target of $10.</li>
<li>XTL Biopharmaceuticals Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTLB#NASDAQ">XTLB</a>) shares climbed 10.5% to $2.31 after falling around 5% on Friday. XTL recently entered into definitive agreement to acquire The Social Proxy.</li>
<li>Mirum Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRM#NASDAQ">MIRM</a>) gained 10.2% to $28.58. Mirum&#8217;s Volixibat achieved interim analyses in VANTAGE PBC and VISTAS PSC studies.</li>
<li>Ouster, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) shares rose 8.5% to $11.21. Ouster Director Virginia Boulet bought a total of 10,000 shares at an average price of $10.30.</li>
<li>Primo Water Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRMW#NASDAQ">PRMW</a>) gained 7.8% to $24.08 after the company and BlueTriton agreed to merge.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Aerovate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTE#NASDAQ">AVTE</a>) shares dipped 90.8% to $2.26 after the company reported 24-week topline results from phase 2b portion of IMPAHCT evaluating AV-101 for pulmonary arterial hypertension.</li>
<li>Kaival Brands Innovations Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KAVL#NASDAQ">KAVL</a>) shares dipped 33% to $3.9950. Kaival Brands Innovations Group shares jumped 338% on Friday after the company announced a $5 million offering of 3,012,048 units at $1.66 per unit.</li>
<li>Bluejay Diagnostics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) fell 29.4% to $0.36 in pre-market trading after jumping 12% on Friday.</li>
<li>Workhorse Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) declined 26% to $2.22. Workhorse announced a 1-for-20 reverse stock split of its common stock last week after shareholders approved the move at the company's annual meeting of stockholders in May.</li>
<li>AMC Networks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMCX#NASDAQ">AMCX</a>) fell 25.7% to $11.67 after the company announced a private offering of $125 million of convertible senior notes.</li>
<li>iPower Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NYSE">IPW</a>) shares fell 24.4% to $2.49 after the company announced a $5 million registered direct offering.</li>
<li>Scorpius Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#NASDAQ">SCPX</a>) fell 21.3% to $0.0763 after the company received NYSE American notice of delisting and reported plans to appeal.</li>
<li>Atara Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRA#NASDAQ">ATRA</a>) declined 20.8% to $0.4044. Atara Biotherapeutics announced a 1-for-25 reverse stock split.</li>
<li>22nd Century Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) dipped 20.7% to $0.6405.</li>
<li>SELLAS Life Sciences Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLS#NASDAQ">SLS</a>) fell 20.6% to $1.19. SELLAS Life Sciences announced review of ongoing Phase 3 REGAL clinical trial of Galinpepimut-S in acute myeloid leukemia by IDMC.</li>
<li>Virgin Galactic Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) dipped 19.6% to $11.00.</li>
<li>Feutune Light Acquisition Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLFV#NASDAQ">FLFV</a>) shares fell 18.5% to $7.99.</li>
<li>MYT Netherlands Parent B.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYTE#NASDAQ">MYTE</a>) declined 13.1% to $4.31.</li>
<li>Biomea Fusion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) fell 12.8% to $4.9190.</li>
<li>BIMI Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIMI#NASDAQ">BIMI</a>) shares fell 12.6% to $1.92 after gaining 23% on Friday.</li>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) fell 12.2% to $0.2451.</li>
<li>La Rosa Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRHC#NASDAQ">LRHC</a>) shares declined 11.1% to $1.04. La Rosa Holdings shares jumped around 76% on Friday after the company filed a request for the withdrawal of its registration statement on a Form S-1.</li>
<li>Evotec SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NYSE">EVO</a>) shares declined 10.5% to $4.07.</li>
<li>ZKH Group Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZKH#NYSE">ZKH</a>) fell 10.2% to $3.5850. ZKH Group recently announced a $50 million share repurchase program.</li>
<li>Bitdeer Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) declined 9% to $9.05.</li>
<li>FuelCell Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCEL#NASDAQ">FCEL</a>) fell 6.8% to $0.7636.</li>
<li>Louisiana-Pacific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPX#NYSE">LPX</a>) declined 6.3% to $86.25 after Goldman Sachs downgraded the stock from Neutral to Sell and lowered its price target from $89 to $81.</li>
<li>Coeur Mining, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>) fell 5.3% to $5.44.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/06/39357134/wall-streets-most-accurate-analysts-spotlight-on-3-materials-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields</a>

Movers

AGRI

AMCX

ATRA

BIMI

BJDX

BMEA

BTDR

CETX

CNSP

EVTV

FCEL

FLFV

KAVL

LRHC

LXRX

MEDS

MIRM

MYTE

NDRA

OUST

PRMW

SCNI

SCPX

SPCE

SYNX

TRNR

VERO

XPOF

XTLB

XXII

Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session

TD Cowen analyst Hoang Nguyen maintains Aarons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) with a Hold and raises the price target from $8 to $10.1.

TD Cowen Maintains Hold on Aarons, Raises Price Target to $10.1

<h3>Gainers</h3>
<ul>
<li>Aarons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) stock increased by 32.5% to $9.99 during Monday's regular session. The company's market cap stands at $306.1 million. </li>
<li>Envirotech Vehicles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVTV#NASDAQ">EVTV</a>) shares rose 28.78% to $1.7. The market value of their outstanding shares is at $27.5 million. </li>
<li>Xponential Fitness (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) shares increased by 26.53% to $14.26. The company's market cap stands at $450.3 million. </li>
<li>Polestar Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) stock moved upwards by 20.27% to $0.82. The market value of their outstanding shares is at $1.7 billion. </li>
<li>EpicQuest Education Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEIQ#NASDAQ">EEIQ</a>) stock rose 19.04% to $1.0. The company's market cap stands at $12.3 million. </li>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) shares increased by 16.26% to $23.02. The market value of their outstanding shares is at $462.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Kaival Brands Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KAVL#NASDAQ">KAVL</a>) shares decreased by 34.1% to $3.93 during Monday's regular session. The company's market cap stands at $11.2 million. </li>
<li>Connexa Sports Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYAI#NASDAQ">YYAI</a>) shares fell 25.72% to $0.5. The market value of their outstanding shares is at $20.3 million. </li>
<li>Volcon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares declined by 12.9% to $4.12. The company's market cap stands at $1.2 million. </li>
<li>MOGU (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOGU#NYSE">MOGU</a>) stock fell 12.74% to $2.66. The company's market cap stands at $21.8 million. </li>
<li>Kaixin Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) stock decreased by 11.61% to $0.13. The company's market cap stands at $7.9 million. </li>
<li>Zapp Electric Vehicles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) shares decreased by 11.06% to $1.93. The company's market cap stands at $6.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EEIQ

FTEL

KXIN

MOGU

PSNY

VLCN

Connexa Sports Technologies Inc. - Common Stock

YYAI

ZAPP

12 Consumer Discretionary Stocks Moving In Monday's Intraday Session

U.S. stocks traded mixed midway through trading, with the S&amp;P 500 edging higher on Monday.
The Dow traded up 0.08% to 38,618.63 while the NASDAQ rose 0.20% to 17,724.07. The S&amp;P 500 also rose, gaining, 0.24% to 5,444.69.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/06/39354484/top-4-risk-off-stocks-that-may-rocket-higher-in-q2">Top 4 Risk Off Stocks That May Rocket Higher In Q2</a>
Leading and Lagging Sectors Consumer staples shares jumped by 0.4% on Monday.
In trading on Monday, utilities shares fell by 1%.
Top Headline
The NY Empire State Manufacturing Index rose to -6 in June versus a reading of -15.6 in May and coming in better than market expectations of -12.50.
<h3 class="wp-block-heading">Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>Mustang Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares shot up 240% to $0.4399 after the company announced safety and efficacy data from the complete Waldenstrom Macroglobulinemia cohort of its Phase 1/2 clinical trial of MB-106, showing an overall response rate of 90% with one patient remaining in complete remission at 31 months.</li>
<li>Shares of Allego N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLG#NASDAQ">ALLG</a>) got a boost, surging 127% to $1.67 after the company and its majority shareholder, Meridiam, announced a transaction framework agreement under which Meridiam will launch a tender offer for all issued and outstanding Allego shares not owned by Meridiam, with the option to tender shares for $1.70 per share in cash.</li>
<li>The Aaron&#8217;s Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) shares were also up, gaining 32% to $9.98 after the company announced that it entered into a definitive agreement to be acquired by IQVentures Holdings.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Aerovate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTE#NASDAQ">AVTE</a>) shares dropped 91% to $2.21. Aerovate Therapeutics released topline results from the Phase 2b portion of the IMPAHCT Phase 2b/3 trial of AV-101, a dry powder inhaled formulation of imatinib, for pulmonary arterial hypertension (PAH).</li>
<li>Shares of Workhorse Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) were down 20% to $2.3950 as the stock begins trading on a split-adjusted basis. Workhorse announced a 1-for-20 reverse stock split of its common stock last week after shareholders approved the move at the company's annual meeting of stockholders in May.</li>
<li>Ovid Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OVID#NASDAQ">OVID</a>) was down, falling 68% to $1.04 after Takeda&#8217;s Skyline study in Dravet syndrome missed its primary endpoint</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/earnings/24/06/39355343/how-to-earn-500-a-month-from-steelcase-stock-ahead-of-q1-earnings-report">How To Earn $500 A Month From Steelcase Stock Ahead Of Q1 Earnings Report</a>
Commodities In commodity news, oil traded up 1.2% to $79.36 while gold traded down 0.4% at $2,339.00.
Silver traded up 0.1% to $29.485 on Monday, while copper fell 1.7% to $4.4210.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 slipped 0.02%, Germany's DAX rose 0.27% and France's CAC 40 gained 0.67%. Spain's IBEX 35 Index fell 0.50%, while London's FTSE 100 slipped 0.15%.
Wages in the Eurozone increased 5.3% year-over-year in the first quarter, while hourly labor costs climbed by 5.1% annually in the quarter.
Spain&#8217;s trade gap widened to EUR 4.7 billion in April from EUR 4.4 billion in the year-ago month. Italy's annual inflation rate came in unchanged at 0.8% in May.
Asia Pacific Markets
Asian markets closed lower on Monday, with Japan's Nikkei falling 1.83%, Hong Kong's Hang Seng Index declining 0.03% and China's Shanghai Composite Index dipping 0.55%.
China&#8217;s retail sales climbed by 3.7% year-over-year in May, while industrial production rose by 5.6% year-over-year in May. China's new home prices fell by 3.9% year-over-year during the month of May. The People's Bank of China kept the interest rate unchanged at 2.50% during its recent meeting. Japanese core machinery orders slipped l 2.9% month-over-month to 885.3 billion yen in April.
Economics
The NY Empire State Manufacturing Index rose to -6 in June versus a reading of -15.6 in May and coming in better than market expectations of -12.50.
Now Read This: <a href="https://www.benzinga.com/news/24/06/39354679/this-analyst-with-86-accuracy-rate-sees-over-13-upside-in-alphabet-here-are-5-stock-picks-for-last-w">This Analyst With 86% Accuracy Rate Sees Over 13% Upside In Alphabet &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a>

Crude Oil Rises 1%; Mustang Bio Shares Spike Higher

U.S. stocks were mostly lower, with the Dow Jones index falling around 0.2% on Monday.
Shares of The Aaron&#8217;s Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) rose sharply during Monday's session after the company announced that it entered into a definitive agreement to be acquired<a href="https://www.benzinga.com/markets/equities/24/06/39355382/why-lease-to-own-retailer-aarons-shares-are-surging-today"> by IQVentures Holdings</a>.
IQVentures will acquire the company for $10.10 per share in cash, or an enterprise value of approximately $504 million.&nbsp;
Aaron&#8217;s shares jumped 32.2% to $9.97 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Xponential Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) gained 21.3% to $13.68. Xponential Fitness announced the appointment of Mark King as Chief Executive Officer.</li>
<li>Lexicon Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXRX#NASDAQ">LXRX</a>) jumped 10.5% to $2.0099. HC Wainwright &amp; Co. analyst Joseph Pantginis initiated coverage on Lexicon Pharmaceuticals with a Buy rating and announced a price target of $10.</li>
<li>Mirum Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRM#NASDAQ">MIRM</a>) rose 10.2% to $28.58. Mirum&#8217;s Volixibat achieved interim analyses in VANTAGE PBC and VISTAS PSC studies.</li>
<li>United Homes Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UHG#NASDAQ">UHG</a>) gained 9.6% to $7.74.</li>
<li>Ouster, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) shares climbed 8.5% to $11.21. Ouster Director Virginia Boulet bought a total of 10,000 shares at an average price of $10.30.</li>
<li>Lufax Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LU#NYSE">LU</a>) gained 8.1% to $2.3787.</li>
<li>Primo Water Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRMW#NASDAQ">PRMW</a>) shares rose 7.8% to $24.08 after the company and BlueTriton agreed to merge.</li>
<li>Golar LNG Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLNG#NASDAQ">GLNG</a>) gained 4.8% to $28.75.</li>
<li>Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) rose 4.4% to $235.84 following a report suggesting that Starboard has a $500 million stake in the company.</li>
<li>Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) gained 3% to $54.22.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/06/39357158/23m-bet-on-pbf-energy-check-out-these-4-stocks-insiders-are-buying">$23M Bet On PBF Energy? Check Out These 4 Stocks Insiders Are Buying</a>

ADSK

GLNG

Aaron's, Mirum Pharmaceuticals, Primo Water And Other Big Stocks Moving Higher On Monday

Shares of Nurix Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRIX#NASDAQ">NRIX</a>) rose sharply in today's pre-market trading after the company announced results from its ongoing clinical trial of NX-5948 in patients with relapsed refractory <a href="https://www.benzinga.com/quote/NRIX/news">chronic lymphocytic leukemia</a>.
Nurix Therapeutics shares jumped 12.1% to $17.01 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Scinai Immunotherapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) rose 89.4% to $6.61 in pre-market trading after surging 24% on Friday. Scinai Immunotherapeutics, last week, received a non-binding Letter of Intent from the European Investment Bank for converting loan into equity.</li>
<li>Interactive Strength Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) shares rose 76.6% to $5.05 in pre-market trading after dipping 19% on Friday.</li>
<li>ENDRA Life Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDRA#NASDAQ">NDRA</a>) gained 36.4% to $0.1414 in pre-market trading after a 13G filing showed a 9.99% passive stake from S.H.N. Financial Investments Ltd.</li>
<li>The Aaron&#8217;s Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) gained 32.1% to $9.96 in pre-market trading after the company announced that it entered into a definitive agreement to be acquired by IQVentures Holdings.</li>
<li>Venus Concept Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) gained 26.1% to $1.18 in pre-market trading after the company announced that it has entered a new strategic resurfacing and skin tightening device supply arrangement with Skin Laundry Holdings.</li>
<li>SRIVARU Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVMH#NASDAQ">SVMH</a>) shares gained 16.4% to $0.2649 in pre-market trading. SRIVARU shares jumped 49% on Friday after the company announced it will begin accepting paid reservations and bookings for its flagship product, the PRANA 2.0, on June 16th.</li>
<li>Kineta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KA#NASDAQ">KA</a>) rose 15.4% to $0.5990 in pre-market trading after gaining around 10% on Friday.</li>
<li>IceCure Medical Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICCM#NASDAQ">ICCM</a>) shares rose 14% to $0.93 in pre-market trading after gaining around 8% on Friday.</li>
<li>XTL Biopharmaceuticals Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTLB#NASDAQ">XTLB</a>) shares climbed 13.4% to $2.37 in pre-market trading after falling around 5% on Friday. XTL recently entered into definitive agreement to acquire The Social Proxy.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Ovid Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OVID#NASDAQ">OVID</a>) shares fell 64.1% to $1.18 in pre-market trading after Takeda&#8217;s Skyline study in Dravet syndrome missed its primary endpoint</li>
<li>Kaival Brands Innovations Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KAVL#NASDAQ">KAVL</a>) shares fell 33.2% to $3.98 in pre-market trading. Kaival Brands Innovations Group shares jumped 338% on Friday after the company announced a $5 million offering of 3,012,048 units at $1.66 per unit.</li>
<li>iPower Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NYSE">IPW</a>) shares fell 28.7% to $2.35 in pre-market trading after the company announced a $5 million registered direct offering.</li>
<li>Bluejay Diagnostics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) fell 22% to $0.3980 in pre-market trading after jumping 12% on Friday.</li>
<li>Feutune Light Acquisition Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLFV#NASDAQ">FLFV</a>) shares fell 17.8% to $8.06 in pre-market trading.</li>
<li>BIMI Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIMI#NASDAQ">BIMI</a>) shares fell 15.6% to $1.86 in pre-market trading after gaining 23% on Friday.</li>
<li>La Rosa Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRHC#NASDAQ">LRHC</a>) shares declined 12.8% to $1.02 in pre-market trading. La Rosa Holdings shares jumped around 76% on Friday after the company filed a request for the withdrawal of its registration statement on a Form S-1.</li>
<li>Zapp Electric Vehicles Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) shares dipped 12% to $1.91 in pre-market trading after dipping over 10% on Friday.</li>
<li>AMC Networks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMCX#NASDAQ">AMCX</a>) fell 9.4% to $14.24 in pre-market trading after the company announced a private offering of $125 million of convertible senior notes.</li>
<li>Evotec SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NYSE">EVO</a>) shares declined 7.7% to $4.20 in pre-market trading.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/06/39350959/investor-optimism-continues-to-wane-despite-nasdaqs-fifth-consecutive-record-close-on-friday">Investor Optimism Continues To Wane Despite Nasdaq&#8217;s Fifth Consecutive Record Close On Friday</a>

ICCM

NRIX

SVMH

Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Aaron&#8217;s Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) shares are surging after the lease-to-own retailer entered into a definitive agreement to be <a target="_blank" href="https://www.benzinga.com/pressreleases/24/06/n39352924/the-aarons-company-enters-into-definitive-agreement-to-be-acquired-by-iqventures-for-10-10-per-sha" rel="noreferrer noopener">acquired by the fintech organization IQVentures Holdings, LLC</a>.
IQVentures will acquire the company for $10.10 per share in cash, or an enterprise value of approximately $504 million.&nbsp;
The price represents a premium of 34.0% over the company&#8217;s closing share price of $7.54 on June 14, 2024.
&#8220;With the assistance of our financial and legal advisors, the Board conducted a thorough review of our strategic options and ultimately determined that a sale to IQVentures represented the best way to maximize shareholder value,&#8221; said Chairman John W. Robinson III.
The transaction is expected to close by the end of the year, subject to shareholder approval, regulatory approval and other customary closing conditions.
After the closing of the transaction, the Aaron&#8217;s Company will become a privately held company, and its common stock will no longer be traded on NYSE.
The Aaron&#8217;s Company will continue to operate under its existing brand names and will maintain its headquarters in Atlanta, Georgia.
Price Action: AAN shares are trading higher by 32.2% at $9.97 in premarket at the last check Monday.
Photo via Shutterstock

Equities

Media

General

Why Lease-To-Own Retailer Aaron's Shares Are Surging Today

WIIM

Aarons Holdings shares are trading higher after the company announced that it entered into a definitive agreement to be acquired by IQVentures Holdings.

Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Mueller Water Products (MWA – Research Repor...

Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Mueller Water Products (MWA), CNH Industrial (CNH) and Aaron's Company (AAN)

Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Aaron's Company (AAN – Research Report), Aec...

Analysts Offer Insights on Industrial Goods Companies: Aaron's Company (AAN), Aecom Technology (ACM) and Ameresco (AMRC)

Downgrading Haverty Furniture Companies On Accelerating Weakness

Catalyst Watch: Spotlight on Micron, Southwest Airlines, and FOMC speakers

Aaron's falls as close date for sale to IQVentures delayed a few days

Aaron's Company ( ($AAN) ) just unveiled an announcement. The Aaron's Company and IQVentures have announced the expected completion of their acquis...

Aaron's Company Acquisition by IQVentures Nears Completion

Aaron's gains as IQVentures says deal will close on Thursday

Aaron's gains as IQVentures says deal will close on Thursday (update)

Aaron's Company ( ($AAN) ) has issued an update. The Aaron's Company, a prominent provider of lease-to-own and retail purchase solutions, has been ...

Aaron's Company Acquired by IQVentures for $504 Million

Aaron's Company ( ($AAN) ) has shared an announcement. In a significant corporate development, shares of a company's common stock were converted in...

Aaron's Company Finalizes Merger and Announces Delisting

AERG

ALXO

AMRC

ARHS

AZUL

BIRK

BMRN

BRZE

COST

ETON

HOFT

HUBS

IART

IMRX

INTU

KIRK

LUNR

MPAA

NBIX

NXST

PGHL

SFIX

SNBR

VERV

VSTO

ZETA

Press Releases

Kuehn Law Encourages SILK, SGE, AAN, and PRMW Investors to Contact Law Firm

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, AAN, PRMW, SGE on Behalf of Shareholders

Dividends

Aaron's Directors Declare Cash Dividend

The Aaron's Company, Inc. Reports Second Quarter 2024 Financial Results

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMBC, DO, AAN, SHCR on Behalf of Shareholders

AARON'S INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of The Aaron's Company, Inc. - AAN

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENV, AAN, INFN on Behalf of Shareholders

AAN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of The Aaron's Company, Inc. Is Fair to Shareholders

IQVentures To Complete Acquisition of The Aaron's Company

IQVentures Completes Acquisition of The Aaron's Company

AMBC

INFN

SHCR

SILK

Jefferies

Loop Capital

Truist Securities

TD Cowen

Stephens & Co.

월스트리트에는 &#8216;갭 리필(Gap refill)&#8217;이라는 옛말이 있다. 이는 사실이며 아론스 홀딩스 컴퍼니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>)의 차트에서 확인할 수 있다. 이 기사에서는 이것이 사실인 이유와 <a href="https://www.benzinga.com/trading-ideas/technicals" target="_blank" rel="noopener" data-google-interstitial="false">발생하는 이유</a>를 설명한다.
금융 시장에서 중요한 역학은 이전에 지지선에서 저항선으로 전환되었던 가격 수준이다. 이는 매수자의 변심으로 인해 발생한다.
사람들은 매입한 후 가격이 지불한 가격보다 낮아지면 구매를 후회한다. 일부는 가격이 진입 수준으로 다시 상승하면 나가기로 결정하고 손익분기점에 매도할 수 있다. 결과적으로 주가가 매수 가격까지 회복되면 해당 수준에서 매도 주문을 한다. 매도 주문이 충분하면 지지대였던 가격에서 저항이 형성된다.
이는 차트에서 확인할 수 있다. 11.80달러 수준은 2023년 8월에 지지선으로 작용했다. 그 후 2023년 12월에는 저항선으로 작용했다.
또 다른 중요한 시장 역학은 저항이 지지로 바뀌는 가격 수준이다. 10.80달러가 2023년 9월 저항이었다가 다음 1월 지지가 되었기 때문에 이는 차트에서도 볼 수 있다.
이는 판매자의 변심으로 인해 발생한다. 일부 투자자와 거래자는 가격이 더 높아지면 매도를 후회한다. 그들 중 다수는 자신의 주식을 다시 사겠다고 맹세했지만, 이는 매각 당시와 동일한 가격으로 주식을 얻을 수 있는 경우에만 가능하다.
그래서 그들은 저항했던 가격에 매수 주문을 했다. 이러한 매수 주문이 충분하면 저항이었던 가격이 지지로 바뀔 것이다.
<img decoding="async" src="https://www.benzinga.com/files/u449135/aaron_chart.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
&#8216;갭&#8217;은 주식이 특정 가격으로 마감되었다가 다음날 다른 가격으로 시작될 때 발생한다. 이 두 가격 사이의 수준에서는 거래가 없다. 따라서 이 범위 내에서 매수 또는 매도한 트레이더나 투자자는 없다. 이는 자신의 주식을 다시 팔거나 사려고 후회하는 구매자나 판매자가 없을 것임을 의미한다.
따라서 주식이 한 방향으로 향하는 가격 수준을 통해 갭을 벌린 다음 결국 반대 방향으로 동일한 수준으로 되돌아가는 경우 매수 또는 매도 관심이 부족하기 때문에 해당 가격 수준을 빠르게 되돌리는 경향이 있다.
이로써 갭을 ‘다시 메우는(refill)&#8217; 현상이 발생하는 것이다.
2023년 4월 AAN은 10.22달러에서 12.25달러로 갭이 발생했다. 이 차트에서 볼 수 있듯이 이 갭은 다음해 8월에 채워졌다.
2023년 10월 주가는 8.89달러에서 7.28달러로 하락하며 갭을 만들었다. 주가는 11월에 반전되어 이 갭을 다시 메웠다.
월스트리트에는 많은 말이 있는데, &#8216;갭 채우기&#8217;도 그 중 하나이며 사실이다.
이미 읽어보셨나요? <a href="https://www.benzinga.com/general/gaming/24/06/39362295/gamestop-shareholders-meeting-highlights-actions-speak-louder-than-words-says-ceo-ryan-cohen">게임스탑 주주총회의 하이라이트: ‘행동이 말보다 중요하다&#8217;고 말하는 CEO 라이언 코헨</a>
이미지는 Midjourney를 통해 인공 지능을 사용하여 생성되었습니다.

Comments

Aaron's Co Inc (The) Com

뉴스

에 대한 최신 뉴스 Aaron's Co Inc (The) Com (NYSE:AAN) 주식

화요일, 6월 18, 2024

뉴스

파트너 / 기고자

벤징가 글로벌